Találati lista | Tudóstér

001-es BibID:	BIBFORM094325
Első szerző:	Ignat, Simona-Rebeca
Cím:	Complexation with Random Methyl-β-Cyclodextrin and (2-Hydroxypropyl)-β-Cyclodextrin Promotes Chrysin Effect and Potential for Liver Fibrosis Therapy / Simona-Rebeca Ignat, Sorina Dinescu, Judit Váradi, Ferenc Fenyvesi, Thi Le Phuong Nguyen, Alina Ciceu, Anca Hermenean, Marieta Costache
Dátum:	2020
ISSN:	1996-1944 1996-1944
Megjegyzések:	Liver fibrosis results from chronic liver injury and is characterized by the accumulation of extracellular matrix in excess driven by hepatic stellate cells (HSCs) activation. Chrysin (CHR) is a natural flavonoid that is limited by its low solubility to exert its anti-inflammatory, antioxidant and anti-fibrotic properties. The aim of this study was to investigate the biocompatibility of CHR complexes with two cyclodextrins (CDs)-(2-hydroxypropyl)- -cyclodextrin (HPBCD) and random methyl- -cyclodextrin (RAMEB), and their potential to induce anti-inflammatory, antioxidant and anti-fibrotic e ects. Biocompatibility of the complexes was evaluated on Huh7 and LX2 cell lines: MTT and Live/Dead tests indicated the cell viability and an LDH test showed the cytotoxicity. Immunohistochemical staining of Nuclear Factor Kappa B (NF- B) nuclear translocation was performed to evaluate the anti-inflammatory e ect of the complexes. Oxygen Radical Absorbance assay, Superoxide Dismutase activity and Glutathione Peroxidase (GPx) assays indicated the antioxidant properties of the chrysin complexes. Finally, the complexes' anti-fibrotic potential was evaluated at the protein and gene level of -sma. In HSCs, CDs induced higher cytotoxicity correlated with lower cell viability than CHR?CD. The 1:1 CHR?RAMEB pretreatment avoided p65 translocation. The 1:2 CHR?RAMEB complex increased ORAC values, improved SOD activity and produced the highest stimulation of GPx activity. CHR?RAMEB reduced -sma expression at lower concentration than CHR?HPBCD, proving to be more e cient. In conclusion, both CHR?CD complexes proved to be biocompatible, but CHR?RAMEB showed improved anti-inflammatory, antioxidant and anti-fibrotic e ects that could recommend its further use in liver fibrosis treatment.
Tárgyszavak:	Orvostudományok Gyógyszerészeti tudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk
Megjelenés:	Materials. - 13 : 21 (2020), p. 1-14. -
További szerzők:	Dinescu, Sorina Váradi Judit (1973-) (gyógyszerész, gyógyszertechnológus) Fenyvesi Ferenc (1977-) (gyógyszerész, gyógyszertechnológus) Nguyen, Thi Le Phuong Ciceu, Alina Hermenean, Anca Costache, Marieta
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: